Brain Cancer Diagnostic Error Could Lead to Misclassification of Deadly Tumors
New research reveals a critical flaw in brain tumor diagnosis that could affect treatment decisions for aggressive cancers.
697 articles in this topic
New research reveals a critical flaw in brain tumor diagnosis that could affect treatment decisions for aggressive cancers.
Editorial raises concerns about influential 2009 study on Cerebrolysin's effects on brain degeneration in Alzheimer's models.
New research reveals how TDP-43 protein causes energy failure in motor neurons, pointing to potential metabolic therapies for ALS.
New research identifies distinct toxic tau protein clusters that drive aggressive Alzheimer's progression, opening doors for personalized treatments.
New research reveals when harmful tau proteins begin accumulating in Down syndrome brains, offering insights into Alzheimer's prevention.
Researchers discover abnormal protein aggregates in skeletal muscle of ALS patients, potentially revealing new disease pathways.
Promising Cerebrolysin research for rare neurological disorder withdrawn, highlighting research integrity concerns.
Scientists discover how brain cells signal distress before myelin damage, offering new targets for MS prevention.
Scientists discover why eye movement neurons survive ALS while spinal neurons die, revealing potential therapeutic targets.
New longitudinal study reveals higher sodium consumption specifically harms episodic memory in cognitively healthy older males.
New research reveals how declining brain lymphatic drainage contributes to Alzheimer's and Parkinson's disease vulnerability.
New brain imaging study identifies specific neurotransmitter pathways that make certain brain regions more vulnerable to Alzheimer's disease.